A major trial found that implantable cardioverter-defibrillators may benefit some patients younger than 70 with mild-to-moderate heart dysfunction and cardiac scarring. A more than decade-long randomized trial suggests that implantable cardioverter-defibrillators may benefit some patients who have heart scarring and only mild-to-moderate loss of heart function, a group that currently falls outside standard treatment guidelines. [...]

My background in experimental physics has led me to critically think about the darkness in human nature and its linkage to global depopulation through vaccines. I question the safety and efficacy of vaccines as recent studies show. There is no such thing as a good vaccine.